Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce F Bebo

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2024
The refined Pathways to Cures Research Roadmap for multiple sclerosis curesBruce F Bebo, Brenda L Banwell, Caroline C Whitacre, et al.
The Journal of Biological Chemistry|August 7, 2012
Hyaluronan anchored to activated CD44 on central nervous system vascular endothelial cells promotes lymphocyte extravasation in experimental autoimmune encephalomyelitisClayton W Winkler, Scott C Foster, Steven G Matsumoto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2022
Pathways to cures for multiple sclerosis: A research roadmapBruce F Bebo, Mark Allegretta, Douglas Landsman, et al.
Nature Medicine|August 9, 2005
Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturationStephen A Back, Therese M F Tuohy, Hanqin Chen, et al.
Multiple Sclerosis and Related Disorders|January 5, 2025
Self-reported longitudinal COVID-19 vaccination reactogenicity profiles in persons with multiple sclerosisFarren B S Briggs, Hollie Schmidt, Farrah J Mateen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Vaccination Reactogenicity in Persons With Multiple SclerosisFarren Basil Shaw Briggs, Farrah J Mateen, Hollie Schmidt, et al.
Journal of the American Academy of Dermatology|August 1, 2012
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasisHowa Yeung, Joy Wan, Abby S Van Voorhees, et al.
Archives of Dermatology|April 18, 2012
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice settingJoel M Gelfand, Joy Wan, Kristina Callis Duffin, et al.
Archives of Dermatology|January 18, 2012
Consensus guidelines for the management of plaque psoriasisSylvia Hsu, Kim Alexander Papp, Mark G Lebwohl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2020
COVID-19 in people with multiple sclerosis: A global data sharing initiativeLiesbet M Peeters, Tina Parciak, Clare Walton, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2024
The refined Pathways to Cures Research Roadmap for multiple sclerosis curesBruce F Bebo, Brenda L Banwell, Caroline C Whitacre, et al.
The Journal of Biological Chemistry|August 7, 2012
Hyaluronan anchored to activated CD44 on central nervous system vascular endothelial cells promotes lymphocyte extravasation in experimental autoimmune encephalomyelitisClayton W Winkler, Scott C Foster, Steven G Matsumoto, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2022
Pathways to cures for multiple sclerosis: A research roadmapBruce F Bebo, Mark Allegretta, Douglas Landsman, et al.
Nature Medicine|August 9, 2005
Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturationStephen A Back, Therese M F Tuohy, Hanqin Chen, et al.
Multiple Sclerosis and Related Disorders|January 5, 2025
Self-reported longitudinal COVID-19 vaccination reactogenicity profiles in persons with multiple sclerosisFarren B S Briggs, Hollie Schmidt, Farrah J Mateen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 10, 2021
COVID-19 Vaccination Reactogenicity in Persons With Multiple SclerosisFarren Basil Shaw Briggs, Farrah J Mateen, Hollie Schmidt, et al.
Journal of the American Academy of Dermatology|August 1, 2012
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasisHowa Yeung, Joy Wan, Abby S Van Voorhees, et al.
Archives of Dermatology|April 18, 2012
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice settingJoel M Gelfand, Joy Wan, Kristina Callis Duffin, et al.
Archives of Dermatology|January 18, 2012
Consensus guidelines for the management of plaque psoriasisSylvia Hsu, Kim Alexander Papp, Mark G Lebwohl, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2020
COVID-19 in people with multiple sclerosis: A global data sharing initiativeLiesbet M Peeters, Tina Parciak, Clare Walton, et al.
Pageof 3